Evaluation of P-glycorptotein mediated interaction of the atypical antipsychotic agents risperidone and paliperidone in vitro

被引:0
|
作者
Zhu, Hao-Jie [1 ]
DeVane, C. Lindsay [2 ]
Markowitz, John S. [1 ,2 ]
机构
[1] Med Univ SC, Dept Pharmaceut Sci, Charleston, SC USA
[2] Med Univ SC, Dept Psychiat & Behav Sci, Charleston, SC USA
来源
FASEB JOURNAL | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Risperidone and paliperidone inhibit P-glycoprotein activity in vitro
    Zhu, H. -J.
    Wang, J. -S.
    Markowitz, J. S.
    Donovan, J. L.
    Gibson, B. B.
    DeVane, C. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S264
  • [2] Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro
    Hao-Jie Zhu
    Jun-Sheng Wang
    John S Markowitz
    Jennifer L Donovan
    Bryan B Gibson
    C Lindsay DeVane
    Neuropsychopharmacology, 2007, 32 : 757 - 764
  • [3] Risperidone and paliperidone inhibit P-glycoprotein activity in vitro
    Zhu, Hao-Jie
    Wang, Jun-Sheng
    Markowitz, John S.
    Donovan, Jennifer L.
    Gibson, Bryan B.
    DeVane, C. Lindsay
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (04) : 757 - 764
  • [4] Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions
    André Quincozes-Santos
    Larissa Daniele Bobermin
    Rafaela Pestana Leques Tonial
    Victorio Bambini-Junior
    Rudimar Riesgo
    Carmem Gottfried
    European Archives of Psychiatry and Clinical Neuroscience, 2010, 260 : 475 - 481
  • [5] Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions
    Quincozes-Santos, Andre
    Bobermin, Larissa Daniele
    Leques Tonial, Rafaela Pestana
    Bambini-Junior, Victorio
    Riesgo, Rudimar
    Gottfried, Carmem
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2010, 260 (06) : 475 - 481
  • [6] Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy
    Paulzen, Michael
    Haen, Ekkehard
    Hiemke, Christoph
    Stegmann, Benedikt
    Lammertz, Sarah E.
    Gruender, Gerhard
    Schoretsanitis, Georgios
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (08) : 1668 - 1675
  • [7] Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone
    Kao, Yu-Han
    Chern, Yijuang
    Yang, Hui-Ting
    Chen, Hui-Mei
    Lin, Chun-Jung
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (08): : 1412 - 1423
  • [8] Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
    Melnik, Tamara
    Soares, Bernardo Garcia
    dos Santos Puga, Maria Eduarda
    Atallah, Alvaro Nagib
    SAO PAULO MEDICAL JOURNAL, 2010, 128 (03): : 141 - 166
  • [9] Effects of typical (haloperidol) and atypical (risperidone) antipsychotic agents on protein expression in rat neural stem cells
    Kashem, Mohammed A.
    Ummehany, Rahnuma
    Ukai, Wataru
    Hashimoto, Eri
    Saito, Toshikazu
    Mcgregor, Iain S.
    Matsumoto, Izuru
    NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (07) : 558 - 565
  • [10] Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone
    Liu, Xinghua
    Sun, Heyuan
    Zhang, Yumu
    Sun, Yufei
    Wang, Wenyan
    Xu, Lixiao
    Liu, Wanhui
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 422